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ScienceDirectBiosynthetic pathways provide an enzymatic route from
inexpensive renewable resources to valuable metabolic
products such as pharmaceuticals and plastics. Designing
these pathways is challenging due to the complexities of
biology. Advances in the design and construction of genetic
variants has enabled billions of cells, each possessing a slightly
different metabolic design, to be rapidly generated. However,
our ability to measure the quality of these designs lags by
several orders of magnitude. Recent research has enabled
cells to report their own success in chemical production
through the use of genetically encoded biosensors. A new
engineering discipline is emerging around the creation and
application of biosensors. Biosensors, implemented in
selections and screens to identify productive cells, are paving
the way for a new era of biotechnological progress.
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Metabolic engineering and the evaluation
bottleneck
The enzymatic processes of cellular metabolism perform
chemical conversions with exquisite specificity and speed.
By engineering metabolism, we can harness these process-
es for human needs, such as the industrial production of
organic chemicals, fuels, and polymers. Indeed, these
microbial metabolic products make up a large and rapidly
growing segment of the ‘bioeconomy’ [1,2] (Figure 1a).
Despite its value, metabolic engineering faces significant
challenges to mature as an engineering discipline. Biologi-
cal ‘parts’, such as genes that encode enzymes, or promoters
that direct their expression, can be highly context-depen-
dent. As a result, many design attempts are required before
an optimal set of parts is identified. This problem is
exacerbated by the slow and expensive chromatographicCurrent Opinion in Biotechnology 2016, 42:84–91 methods used to measure cellular chemical production
during design evaluation [3]. Consequently, design-
build-test cycles are painstaking, with development times
measured in years or decades (Figure 1b).
While traditional engineering disciplines have had great
success in a bottom-up approach to design, intracellular
complexity has hampered bottom-up engineering in bi-
ology. Bottom-up design relies on well-characterized
parts that follow well-defined physical rules. This, in
turn, enables the design of whole systems that behave
as theory and calculation would predict. In contrast,
efforts to design whole organisms using bottom-up
approaches are rudimentary. Regardless of the initial
intention of forward engineering, metabolic engineers
must rely on making many modifications to an organism’s
genome before finding a design that works [4].
As a field, metabolic engineering has begun to shift
toward an engineering paradigm relying on principles
borrowed from Darwinian evolution. Because evolution
acts top-down on biological functions rather than mecha-
nisms, coopting evolutionary principles can yield a more
efficient way to achieve biological design goals. Top-
down design is achieved by defining the requirements
of the complete system, without specifying the parame-
ters of the lower-level components. If the top-level design
goal of metabolite production can be evaluated through a
screen or selection, rather than traditional metabolite
measurement techniques, millions of designs can be
evaluated rapidly. This enables an optimal combination
of genetic parts to be determined without comprehensive
knowledge of each individual part.
Screens and selections are enabled by biosensors that
transduce intracellular metabolite concentration into gene
expression changes. When metabolite production is linked
to the expression of a fluorescent protein, high throughput
methods such as flow cytometry can be used to evaluate
potential designs (Figure 1c). Because each individual
design is evaluated, this biosensor configuration is an
example of screening. Alternatively, if the biosensor
actuates the expression of an antibiotic resistance gene,
then only cells producing high levels of the desired com-
pound survive an antibiotic challenge [5]. Selections can
also be engineered through auxotrophy, where gene ex-
pression complements a nutrient deficiency that would
otherwise inhibit growth [6]. Because the collection of
designs is placed in an environment where only the best
survive, and individual designs are not inspected, this is an
example of selection. The choice of using a screen or
selection in a specific metabolic engineering projectwww.sciencedirect.com
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(a) Genome engineering produces products with an annual US market
of $350B. Industrial biotechnology accounts for more than $100B of
that figure [1,2]. (b) Biotechnological progress proceeds through the
design-build-test cycle. Recent breakthroughs have left test-step
throughput lagging behind. (c) Biosensor-based screens and
selections provide a multiplexed solution to design evaluation and
alleviate the test-step bottleneck.
www.sciencedirect.com depends on the specifics of the experiment. Screens may
be more suitable for identifying cells producing toxic
compounds, whereas selections may be simpler if the
design space is very large. Regardless of the paradigm
employed, the single-cell resolution and high throughput
evaluation provided by metabolite biosensors allow mil-
lions of variants to be assayed extremely quickly. Biosen-
sors enable multiplexed phenotype evaluation, which
transforms the engineering design-build-test cycle into
an evolutionary mutate-test cycle, and finally allows engi-
neers to test huge numbers of metabolic pathway designs
in a rapid, iterative manner.
Metabolic design and modification strategies
To understand the need for multiplexed evaluation of
metabolite production within single cells, it is instructive
to inspect the metabolic design and genomic modification
capabilities that are now available. Advances in these ‘de-
sign’ and ‘build’ steps, which can produce so many potential
designs, require similarly high throughput tools to evaluate
their success in achieving metabolic design goals.
Pathway design and strain optimization
It is often the case that a host organism does not
naturally produce a desired compound. In these cases
algorithms that rely on a catalog of known enzymes can
be used to identify the shortest or most economical
routes to the target compound [7]. These heterolo-
gous enzymes can be installed within the working strain
to enable production of the target compound. Such de
novo biosynthetic pathways have enabled biological
production of several valuable compounds. A notable
example was the engineering of Escherichia coli to
produce the non-natural plastic precursor, 1-4-butane-
diol (BDO), requiring addition of five exogenous
enzymes [8]. In this study, over 10,000 pathways were
predicted, a daunting number to evaluate through tra-
ditional methods; only two were chosen for experimen-
tal analysis.
Once a strain can produce a target chemical, further
optimization is necessary to achieve suitable production
outcomes such as metabolite concentration, production
rate and stoichiometric yield. The algorithms and tech-
niques available for pathway prediction and optimization
have been well reviewed [7,9]. Though a great improve-
ment over the nearly infinite space of random mutagene-
sis, these methods still generate thousands to millions of
high quality guesses about which combinations of meta-
bolic changes will yield the most productive strains.
These metabolic designs must be cloned and experimen-
tally tested to identify productive variants and to validate
design methods for further improvement.
Genome engineering
Techniques to encode predicted metabolic designs by
making mutations to microbial genes and genomes in aCurrent Opinion in Biotechnology 2016, 42:84–91
86 Chemical biotechnologytargeted, multiplexed fashion are becoming mature.
Oligonucleotide-mediated genome editing in E. coli,
called multiplexed automated genome engineering
(MAGE), makes use of the phage lambda beta protein
to integrate oligonucleotides bearing desired changes
in the place of Okazaki fragments during DNA replica-
tion [10–12]. CRISPR-based genome editing techniques
are expanding genomic modification techniques to other
bacteria [13] and yeast [14,15]. Multiplexed modifica-
tion of genomes allows the millions of biosynthetic
pathway variants generated by in silico metabolic meth-
ods to be constructed in vivo.
Analogously, advances in DNA synthesis, especially
microarray-synthesized oligonucleotide pools [16],
and the assembly of these pools into full-length genes
[17] are enabling the construction of rationally designed
gene libraries and collections of metagenomically
mined orthologues. Competition among companies
supplying raw oligonucleotide pools — Agilent Tech-
nologies, Custom Array and Twist Biosciences — and
those supplying fully synthesized genes — Blue Heron,
DNA 2.0, Integrated DNA Technologies, Genewiz,
Gen9, Genscript, Twist Biosciences and more — is
driving down the price of DNA [18] and transforming
the capability of metabolic engineers to encode in silico
designs into physical DNA.
The role of biosensors in metabolic
engineering
Chemical measurement is a screening bottleneck
The impact of increased throughput in the design and
construction of genetic elements is diminished while
design evaluation remains a bottleneck. The gold stan-
dard of metabolite measurement, using liquid chroma-
tography or mass spectrometry, is limited to around 103
measurements per instrument, per day, with the best
equipment [19]. More commonly, fewer than 102 mea-
surements can be made per instrument, per day. One
hundred thousand carefully constructed pathway var-
iants, or one hundred million computationally predicted
enzyme active sites are wasted if only a small fraction of
these can be assayed for function.
Conspicuous molecules, which are colorful, fluorescent or
aid cell fitness, illustrate the power of screening multi-
plexed mutants: Wang, et al. were able to optimize the
bioproduction of lycopene, a bright red carotenoid, by
generating an estimated 15 billion unique genetic var-
iants and visually screening almost 106 of these to identify
mutants with the highest reported production titer in just
three days [10]. Most molecules of interest lack such
convenient spectroscopic properties and are not essential
for cell growth. For this majority, a mechanism is required
to couple the presence of the inconspicuous molecule to a
conspicuous reporter or fitness advantage.Current Opinion in Biotechnology 2016, 42:84–91 Biosensors let cells make chemical measurements
A genetically encoded biosensor propagates molecular
recognition of a target molecule into biological actuation
within a cell. In this way, each cell is able to ‘measure’ the
concentration of an intracellular metabolite, and reports
this concentration via a conspicuous gene product, pro-
viding the engineer with a multiplexed method to detect
cell biosynthetic productivity. Both screens (Figure 2a)
and selections (Figure 2b) are used to enrich for produc-
tive cells. Biosensors can be gauged for effectiveness via
several metrics. An ideal biosensor would operate over a
wide range of concentrations, have a high signal-to-noise
ratio, a low false positive rate and high molecular speci-
ficity [3].
The range of concentrations over which the biosensor
exhibits a change in output is the operational range of the
biosensor. Operational range is determined by measuring
the concentrations over which the biosensor shows a
graded, concentration-dependent change in response
(Figure 3a). The desired operational concentration varies
by application: to detect new enzyme activity, nanomolar
sensitivity might be ideal, but millimolar sensitivity
would be more useful in optimizing a pathway to produce
grams per liter of a target compound. Several strategies for
modulating biosensor operational range have been devel-
oped [5].
The signal-to-noise of a biosensor, also referred to as the
dynamic range of the system, can be quantified as the
ratio of the highest measured output of the biosensor to
the lowest measured output of the biosensor (Figure 3a).
Dynamic range can be affected by the number of copies
of the biosensor within the cell [20], or by signal
amplification using an enzymatic reporter [21]. The larger
the dynamic range, the more reliably a true signal can be
discerned from noise.
False positives arise when spurious transcription, transla-
tion or protein activity create an erroneous signal that is
not related to target molecule detection (Figure 3b). The
false positive rate dictates the number of designs that can
be interrogated when searching for rare successes. If the
false positive rate is one in 1000, searching for productive
variants that exist at a rate of one in every 10,000 would
yield a majority of cells that are not actually productive.
Multiple cycles of enrichment may help, but when the
biosensor output is a fitness advantage, such as antibiotic
resistance, cells that erroneously survive may take over
the population. There are a number of genetic modifica-
tions and strategies for counter-selection that drastically
decrease biosensor false positive rates [5].
The most crucial biosensor characteristic is molecular
specificity. For biosensor-directed metabolic engineering
to be possible, a biosensor must be available for the target
molecule. Fortunately, cells have evolved a wide array ofwww.sciencedirect.com
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(a) Biosensor-based screens often rely on linking the production of a fluorescent protein to the intracellular concentration of a target metabolite.
The depicted scheme transduces product concentration into a fluorescent output through the use of an allosterically regulated transcription factor.
Precursor compounds must not activate the biosensor. (b) A similar scheme is depicted for a biosensor-based selection. In this case, the
regulated gene encodes an efflux pump that provides antibiotic resistance. Cells that produce the target molecule will survive an antibiotic
challenge whereas unproductive cells will perish.mechanisms to sense and respond to intracellular metab-
olite concentration.
Generation of new biosensors
Previously developed small molecule biosensors are over-
whelmingly co-opted from the natural sensory machinery
of cells (Table 1). Allosterically regulated transcription
factors (aTFs) change their affinity for an operator DNA
sequence through a conformational change enacted by
ligand binding and are useful for directly controlling gene
transcription [21]. Ligand-dependent protein dimeriza-
tion [22] and ligand-conditional protein stability are re-
lated methods that require binding of a small molecule to
stabilize a protein dimer interface or a protein monomer,
respectively. Stabilization methods lead to direct changes
in fluorescent reporter protein function or mediate tran-
scriptional changes via an additional two-hybrid system.www.sciencedirect.com Riboswitches are 50 untranslated regions composed of
RNA that bind small molecule ligands to control the
stability of the mRNA transcript, directly affecting the
translation of the encoded genes [23,24]. Sensors based on
fluorescence resonance energy transfer (FRET) [25] use a
conformational change in a protein domain brought about
by ligand binding to change the proximity of two fluor-
ophores capable of excitation-emission photon transfer
enabling direct ligand detection. The function of newly
discovered members of bacterial sensory gene families
can often be inferred by their proximity to the operons
they regulate. Metagenomic sequence mining will con-
tinue to expand the repertoire of natural sensors that are
available [26].
Where natural sensory domains have not been found, or
have yet to evolve (i.e. for a synthetic target molecule),Current Opinion in Biotechnology 2016, 42:84–91
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Defining engineering parameters for biosensors is a prerequisite for biosensor-based metabolic engineering to mature. (a) The relationship
between biosensor output and product concentration is the biosensor transfer function. The range of concentrations over which the biosensor
functions is the operational range. The intensity of the biosensor response is the dynamic range. (b) The false positive rate of a biosensor system
determines the maximum number of designs that can be evaluated in a given experiment. A working selection results in enrichment of highly
productive cells. A failed selection results in enrichment of unproductive cells that erroneously survive through mutation or other means.
Table 1
List of natural and engineered biosensors by molecule sensed. Abbreviated sensor type names refer to the following: allosteric TF,
allosteric transcription factor; two-component, two-component systems; FRET, fluorescence resonance energy transfer; GPCR, G-
protein coupled receptor.
Molecule(s) Molecule type Sensor Sensor type Reference
Natural biosensors
1-Butanol Fatty alcohol, fuel BmoR Allosteric TF [35]
Acrylate Plastic precursor AcuR Allosteric TF [20]
Adipate Dicarboxylic acid PcaR Allosteric TF [35]
B12 Vitamin BtuB Riboswitch [50]
Benzoate, naphthalene Aromatics NahR Allosteric TF [51]
Erythromycin Macrolide MphR Allosteric TF [52]
Fatty acids Fatty acid FadR Allosteric TF [53]
Fatty acids Fatty acid GPCR [54]
Glucarate Feedstock CdaR Allosteric TF [55]
Lysine Amino acid LysR Allosteric TF [56]
Muconate Dicarboxylic acid BenM Allosteric TF [57]
NADPH Redox SoxR Allosteric TF [58]
Naringenin Flavonoid TtgR Allosteric TF [59]
Octane Alkane AlkS Allosteric TF [60]
Succinate Dicarboxylic acid DcuR Two-component [35]
Tetracyclines Polyketides TetR Allosteric TF [21]
Engineered biosensors
3,4-Dihydroxybenzoate Aromatic PobR Allosteric TF [28]
Biphenyl, nitrotoluenes Aromatics XylR Allosteric TF [61]
Mevalonate Isoprenoid precursor AraC Allosteric TF [31]
Pyruvate Alpha-keto acid De novo FRET [62]
Theophylline Alkaloid De novo Riboswitch [63]
Thiamine-pp Vitamin De novo Riboswitch [64,65]
Trehalose-6-p Sugar De novo FRET [66]
Triacetic acid lactones Feedstock AraC Allosteric TF [67]
Vanillin Aromatic, flavoring QacR Allosteric TF [29]
Zn2+ Ion De novo FRET [68]
Current Opinion in Biotechnology 2016, 42:84–91 www.sciencedirect.com
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tional design can expand or alter the molecular specificity
of existing sensors, or even create new ones de novo
(Table 1). Computational approaches for engineering
biosensor specificity rely on a range of strategies that
include structure-based predictions [27], homology
modeling [28] and mechanistic insights [29]. Computa-
tional design of ligand binding interfaces has also shown
success [30]. Random mutagenesis, or saturation muta-
genesis of key positions, has shown promise in changing
the specificity of allosteric TFs, including AraC [31] and
LuxR [32].
Biosensors for multiplexed phenotype evaluation
Biosensor-based screens have been demonstrated using a
number of different reporters: fluorescence, insoluble
pigments, luminescence and antibiotic resistance. Bio-
sensors have been used to screen for increased microbial
production of the isoprenoid precursor mevalonate [31],
L-lysine [33,34], 1-butanol [35], and triacetic acid lac-
tones [36]. Luciferase has been used as a reporter to
screen for production of macrolides [37], or to detect
toluene and related compounds [38]. Other recent exam-
ples of biosensor-based screens identifying optimized
production conditions include increased production of
phenol [39], arginine and histidine [40], 3,4 dihydroxy
benzoate [41] and methionine [42].
Biosensor-based selections couple biosensor output to
antibiotic resistance and use cell fitness as a proxy for
target metabolite production. This strategy has been used
to identify improved 1-butanol production plasmids [35]
and for whole-pathway iterated selection resulting in
genomes evolved for higher production of glucarate or
naringenin [5]. Other biosensor-based selections have
been successful in optimizing production of N-acetyl
glucosamine [43] and lysine [44]. In theory, selection
enables library sizes limited only by the size of the
culture. In reality, the false positive rate of the selection
imposes practical constraints that are often far lower.
Fortunately, several strategies exist for attaining desired
false-positive rates [5]. Together, these works demon-
strate that biosensors are a viable strategy for screening to
improve metabolic pathways. Multiplexed engineering in
biology is further explored in a recent perspective [45].
The future of biosensor-based metabolic
engineering
Biosensors offer an attractive, multiplexed phenotype
screening solution with the potential to revolutionize
metabolic engineering. Thus far, pathway production
gains have been modest, and have not approached the
grams per liter production titers mature pathways re-
quired for commercial scale [8]. As an emerging field,
most studies have been proof of concept in nature,
targeting a small number of genes, and using a single
round of screening with a single biosensor. The strategieswww.sciencedirect.com are clever and promising, but not yet ready for industrial
use. Recent work has implemented biosensors beyond
simple screens and selections: biosensors have been used
to tune gene expression of biosynthetic genes in response
to product concentration [46], to modulate mutagenesis
rates in proportion to metabolite production [47], and for
real-time observation of chemical production [48].
To mature as a field, biosensor-directed metabolic engi-
neering requires further characterization of biosensor
systems, coupled with a push toward the discovery and
creation of additional sensor domains that respond to
industrially important compounds. Full biosynthetic
pathways must be targeted [5,49], and multiple sensors
may be required, with graduated operational concentra-
tion ranges to avoid saturating the biosensor at high
molecule titers. To enable very large libraries, of 109
members and above, new interventions to improve ro-
bustness to false positives will be required, which may
benefit from standardized screening chassis [20]. Final-
ly, proof-of-concepts developed in academic labs must be
transferred to industrial partners for final optimization.
Following these recommendations, metabolic engineer-
ing will benefit from a powerful application of evolution-
ary strategies that are ideal to solve this difficult class of
biological problems.
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